Management of erectile dysfunction after radical prostatectomy in 2007

World Journal of Urology

Volumn 25, Issue 2, 2007, Pages 143-148

  Briganti, Alberto ^a   Salonia, Andrea ^a   Gallina, Andrea ^a   Chun, Felix K H ^b   Karakiewicz, Pierre I ^c   Graefen, Markus ^b   Huland, Hartwig ^b   Rigatti, Patrizio ^a   Montorsi, Francesco ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Erectile dysfunction; Prophylaxis; Radical prostatectomy; Treatment

Indexed keywords

PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN E1; VASODILATOR AGENT;

ARTICLE; HUMAN; IMPOTENCE; MALE; PROSTATE TUMOR; PROSTATECTOMY;

ALPROSTADIL; HUMANS; IMPOTENCE; MALE; PHOSPHODIESTERASE INHIBITORS; PROSTATECTOMY; PROSTATIC NEOPLASMS; VASODILATOR AGENTS;

EID: 34047178355     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-007-0148-9     Document Type: Article

References (30)

1. Walsh PC, Donker PJ (1982) Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 128:492-497
2. Walsh PC, Marschke P, Ricker D, et al (2000) Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 55:58-61
3. Walsh PC (2000) Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: A structured debate. J Urol 163:1802-1807
4. Rabbani F, Stapleton AM, Kattan MW, et al (2000) Factors predicting recovery of erections after radical prostatectomy. J Urol 164:1929-1934
5. Stanford JL, Feng Z, Hamilton AS, Gililland FD, et al (2000) Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. JAMA 283:354-360
6. Meuleman EJ, Mulders PF (2003) Erectile function after radical prostatectomy: A review. Eur Urol 43:95-101
7. Montorsi F, Guazzoni G, Strambi LF, et al (1997) Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: Results of a prospective, randomised trial. J Urol 158:1408-1410
8. Brock G, Tu LM, Linet OI (2001) Return of spontaneous erection during long-term intracavernosal alprostadil (Caverject) treatment. Urology 57:536-541
9. Mulhall J, Land S, Parker M, Waters WB, Flanigan RC (2005) The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2:532-545
10. Raina R, Agarwal A, Ausmundson S, Lakin M, Nandipati KC, Montague DK, Mansour D, Zippe CD (2006) Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function. Int J Impot Res 18:77-81
11. Montorsi F, Maga T, Strambi LF, et al (2000) Sildenafil taken at bedtime significantly increases nocturnal erections: Results of a placebo-controlled study. Urology 56:906-911
12. Behr-Roussel D, Gorny D, Mevel K, Caisey S, Bernabè J, Burgess G, Wayman C, Alexandre L, Giuliano F (2005) Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: Lack of tachyphylaxis. Eur Urol 47:87-91
13. Padma-Nathan E, McCullough AR, Giuliano F, et al (2003) Postoperative nightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile function after bilateral nerve-sparing radical prostatectomy. J Urol 4(Suppl):375
14. Bannowsky A, Schulze H, van der Horst C, Seif C, Braun PM, Junemann KP (2006) Nocturnal tumescence: A parameter for postoperative erectile integrity after nerve sparing radical prostatectomy. J Urol 175:2214-2217
15. Schwartz EJ, Wong P, Graydon J (2004) Sildenafil preserves intracorporeal smooth muscle after radical retropubis prostatectomy. J Urol 171:771-774
16. Montorsi F, Salonia A, Gallina A, Zanni G, Saccà A, Dehò F, Briganti A, Grezzi M, Barbieri L, Farina E, Schuit SJ, Rigatti P (2006) There is no significant difference between on-demand PDE5-I vs PDE5-I as rehabilitative treatment in patients treated by bilateral nerve-sparing radical retropubic prostatectomy. In: Proceedings of the meeting of the American Urological Association, Atlanta, 20-25 May
17. Parsons JK, Marschke P, Maples P, Walsh PC (2004) Effect of methylprednisolone on return of sexual function after nerve-sparing radical retropubic prostatectomy. Urology 64:987-990
18. Zippe CD, Jhaveri FM, Klein EA, et al (2000) Role of Viagra after radical prostatectomy. Urology 55:241-245
19. Zagaja GP, Mhoon DA, Aikens JE, Brendler CB (2000) Sildenafil in the treatment of erectile dysfunction after radical prostatectomy. Urology 56:631
20. Raina R, Lakin MM, Agarwal A, Mascha E, Montagne DK, Klein E, Zippe C (2004) Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy. Urology 63:960-966
21. Raina R, Lakin MM, Agarwal A, Sharma R, Goyal KK, Montague DK (2003) Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up. Urology 62:110-115
22. Brock G, Nehra A, Lipshultz LI, et al (2003) Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy. J Urol 170:1278-1283
23. Nehera A, Grantmyre J, Nadel A, Thibonnier M, Brock G (2005) Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy. J Urol 173:2067-2071
24. Montorsi F, Nathan HP, McCullough A, et al (2004) Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: A randomized, double-blind, placebo controlled trial. J Urol 172:1036-1041
25. Nehra A, Blute ML, Barrett DM, et al (2002) Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res 14(Suppl 1):S38-S42
26. Raina R, Agarwal A, Asmundson S, Mansour D, Zippe CD (2005) Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis. Int J Impot Res 17:86-90
27. Gontero P, Fontana F, Bagnasacco A, et al (2003) Is there an optimal time for intracavernous prostaglandin E1 rehabilitation following nonnerve sparing radical prostatectomy? Results from a hemodynamic prospective study. J Urol 169:2166-2169
28. Montorsi F, Guazzoni G, Bergamaschi F, et al (1993) Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence. Urology 42:554-558
29. Raina R, Lakin MM, Thukral M, et al (2003) Long-term efficacy and compliance of intracorporeal (ICI) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis. Int J Impot Res 15:318-322
30. Raina R, Lakin M, Agarwal A, Asmundson S, Montagne D, Zippe CD (2004) Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy. Urology 63:532-538